Browsing by Author Zhuo, Minglei

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 61 next >
Issue Date Title Author(s)
2015 Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. Wang, Jie;Wang, Zhijie;Li, Zhenxiang;Shen, Zhirong;Fu, Shuai;Liu, Zhentao;Cheng, Liang;Bai, Hua;Duan, Jianchun;Zhao, Jun;Wang, Shuhang;Zhuo, Minglei
2015 Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. Wang, Jie;Wang, Zhijie;Li, Zhenxiang;Shen, Zhirong;Fu, Shuai;Liu, Zhentao;Cheng, Liang;Bai, Hua;Duan, Jianchun;Zhao, Jun;Wang, Shuhang;Zhuo, Minglei
Apr-2020 Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors Wang, Zhijie;Duan, Jianchun;Wang, Guoqiang;Zhao, Jing;Xu, Jiachen;Han, Jiefei;Zhao, Zhengyi;Zhao, Jun;Zhu, Bo;Zhuo, Minglei;Sun, Jianguo;Bai, Hua;Wan, Rui;Wang, Xin;Fei, Kailun;Wang, Shuhang;Zhao, Xiaochen;Zhang, Yuzi;Huang, Mengli;Huang, Depei;Qi, Chuang;Gao, Chan;Bai, Yuezong;Dong, Hua;Xiong, Lei;Tian, Yanhua;Wang, Di;Xu, Chunwei;Wang, Wenxian;Li, Junling;Hu, Xingsheng;Cai, Shangli;Wang, Jie
2013 Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer Wang, Shuhang;An, Tongtong;Duan, Jianchun;Zhang, Lijian;Wu, Meina;Zhou, Qinghua;Chen, Jinfeng;Zhuo, Minglei;Yang, Lu;Wang, Yuyan;Bai, Hua;Wang, Jie
Jul-2020 Analysis of MET kinase domain rearrangement in NSCLC Zhuo, Minglei;Liang, Zhen;Yi, Yuting;Wu, Nan;Yang, Xue;Zhong, Jia;Chen, Xiaohan;Huang, Yi;Yu, Zicheng;Liu, Chang;Zeng, Xiaoling;Gu, Wenguang;Zhao, Jun
2013 ANALYSIS OF SENSITIVITY OF LUNG SQUAMOUS CARCINOMA WITH EGFR MUTATION TO EGFR-TKIS AND RESISTANT MECHANISM Wang, Zhijie;Li, Zhenxiang;Yang, Xiaodan;Bai, Hua;Zhuo, Minglei;Duan, Jianchun;Wang, Jie
2018 Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer Lv, Chunxin;Liu, Xiuju;Zheng, Qiwen;Chen, Hanxiao;Yang, Xue;Zhong, Jia;Wang, Yuyan;Duan, Jianchun;Wang, Zhijie;Bai, Hua;Wu, Meina;Zhao, Jun;Wang, Jie;Wang, Ziping;An, Tongtong;Zhuo, Minglei
2019 Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel Wang, Zhijie;Duan, Jianchun;Cai, Shangli;Han, Miao;Dong, Hua;Zhao, Jun;Zhu, Bo;Wang, Shuhang;Zhuo, Minglei;Sun, Jianguo;Wang, Qiming;Bai, Hua;Han, Jiefei;Tian, Yanhua;Lu, Jing;Xu, Tongfu;Zhao, Xiaochen;Wang, Guoqiang;Cao, Xinkai;Li, Fugen;Wang, Dalei;Chen, Yuejun;Bai, Yuezong;Zhao, Jing;Zhao, Zhengyi;Zhang, Yuzi;Xiong, Lei;He, Jie;Gao, Shugeng;Wang, Jie
2019 cfDNA analysis to reveal association of genomic features with chemotherapy response and survival in patients with pulmonary large-cell neuroendocrine carcinoma. Zhuo, Minglei;Guan, Yan-Fang;Yang, Xue;Hong, Lingzhi;Wang, Yuqi;Li, Zhongwu;Chen, Runzhe;Abbas, Hussein;Zhong, Jia;Chen, Hanxiao;Dong, Zhi;Zhu, Xiang;Li, Jianjie;Roarty, Emily;Rinsurongkawong, Waree;Lewis, Jeff;Futreal, Andrew;Xia, Xuefeng;Zhang, Jianjun;Zhao, Jun
16-Jul-2020 Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience Wang, Lu;Zhao, Jun;An, Tongtong;Wang, Yuyan;Zhuo, Minglei;Wu, Meina;Wang, Ziping;Li, Jianjie;Yang, Xue;Chen, Hanxiao;Zhong, Jia
2013 Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations An, Tongtong;Wang, Jie;Bai, Hua;Wang, Zhijie;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;Wu, Meina;Wang, Yuyan;Wang, Shuhang
20-May-2020 Co-mutation features in treatment-naive EGFR-mutant lung adenocarcinoma. Zhao, Jun;Fan, Zaiwen;Chen, Donghong;Zhuo, Minglei;Liang, Zhen;Li, Lin;Gao, Yun;Wang, Xiaorong;Yu, Zhuo;Cai, Cunliang;Dong, Dapeng;Zhao, Jingquan;Gu, Wenguang;Zhang, Min;Chen, Rongrong;Xia, Xuefeng
12-May-2020 Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib Yuan, Bo;Zhao, Jun;Zhou, Chengzhi;Wang, Xiumei;Zhu, Bo;Zhuo, Minglei;Dong, Xilin;Feng, Jiemei;Yi, Cuihua;Yang, Yunpeng;Zhang, Hua;Zhou, Wangyan;Chen, Zhengtang;Yang, Sheng;Ai, Xinghao;Chen, Kehe;Cui, Xuefan;Liu, Difa;Shi, Chunmei;Wu, Wei;Zhang, Yanjun;Chang, Lianpeng;Li, Jin;Chen, Rongrong;Yang, Shuanying
2017 Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Wan, Rui;Wang, Zhijie;Lee, J. Jack;Wang, Shuhang;Li, Qingqing;Tang, Fuchou;Wang, Jin;Sun, Yu;Bai, Hua;Wang, Di;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;An, Tongtong;Wu, Meina;Chen, Zhaoli;Yang, Zhenlin;Wang, Jie
2013 Cytoplasmic ER beta expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC Wang, Zhijie;Wang, Jie;Wang, Xiaodong;Shen, Zhirong;Ding, Xiaosheng;Bai, Hua;Duan, Jianchun;An, Tongtong;Wang, Yuyan;Zhuo, Minglei;Wang, Shuhang;Wu, Meina
2013 Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer Bai, Hua;Wang, Zhijie;Wang, Yuyan;Zhuo, Minglei;Zhou, Qinghua;Duan, Jianchun;Yang, Lu;Wu, Meina;An, Tongtong;Zhao, Jun;Wang, Jie
2012 The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI Huang, Zhen;Wang, Zhijie;Bai, Hua;Wu, Meina;An, Tongtong;Zhao, Jun;Yang, Lu;Duan, Jianchun;Zhuo, Minglei;Wang, Yuyan;Wang, Shuhang;Wang, Jie
2012 DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer Zhu, Jian;Wang, Yuyan;Duan, Jianchun;Bai, Hua;Wang, Zhijie;Wei, Lai;Zhao, Jun;Zhuo, Minglei;Wang, Shuhang;Yang, Lu;An, Tongtong;Wu, Meina;Wang, Jie
2013 DYNAMIC, QUANTITATIVE, AND NON-INVASIVE ANALYSIS OFT790M MUTATION IN MATCHED PLASMA DNA FROM PRE-AND POST-EGFR-TKI TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER Chen, Rui;Bai, Hua;Wang, Shuhang;Wang, Yuyan;Duan, Jianchun;Wang, Jie;An, Tongtong;Zhuo, Minglei;Wu, Meina
5-May-2021 Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study Yang, Xue;Xia, Yang;Xu, Liyan;Liang, Li;Zhuo, Minglei;Wu, Meina;An, Tongtong;Wang, Ziping;Wang, Yuyan;Li, Jianjie;Zhong, Jia;Chen, Hanxiao;Jia, Bo;Wang, Jingjing;Zhao, Jun
Showing results 1 to 20 of 61 next >